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Endometriosis is defined as the presence of active (i.e. responsive to
hormone stimulation) endometrial tissue outside the uterine cavity. Three
pathogenic theories have been suggested to explain the presence of active
endometrium in ectopic sites: the embryonic theory postulates its
development from embryonic remnants of the Wolffian or Müllerian
ducts; the metaplastic theory postulates the transformation of tissues
originating from the celomic mesothelium in endometrial tissue if
stimulated by hormonal or inflammatory factors; and the migratory or
metastatic theory postulates the migration of endometrial cells through
lymphatic or blood flow and their diffusion through retrograde
menstruation from the tubes into the peritoneal cavity, by direct extension
from the uterine wall by contiguity or after surgical procedures that open
the uterine cavity (i.e. Caesarean section). There is some experimental
proof of the migration/metastatic theory.1,2
Endometriosis generally affects pre-menopausal women and is one of the
main causes of hospitalisation in female patients between 15 and 44 years
of age,3 with a prevalence of around 10%,4,5 although reported figures vary
widely depending on the population under study. It has also been reported
rarely in post-menopausal women receiving substitutive oestrogenic
hormone treatment or affected by ovarian or adrenal tumours with
increased secretion of endogenous oestrogens. Recent clinical data suggest
that low parity and heavy menstrual cycles are risk factors; however,
previous hormone therapies, gynaecological surgery or Caesarean section
must also be taken into account as possible risk factors, supporting the
menstrual reflux aetiopathogenetic hypothesis.5 The disease is characterised
by high local aggressiveness and risk of recurrence and requires both surgical
and hormonal treatment, which is mainly based on luteinising-hormone-
releasing hormone (LHRH) analogues, danazol or oestroprogestins.
Therefore, although biologically benign, endometriosis may be viewed as a
true neoplastic process that can invade and damage all of the pelvic
structures, and exceptionally can also migrate outside the pelvis to the skin
or the lungs.6 Moreover, it must be noted that the malignant degeneration
of endometriosis in endometriocarcinoma is well recognised. 
Although endometriosis can spread in almost any site, and despite the
gradual increase in the number of diagnoses over the last few years
following the diffusion of explorative laparoscopy, urinary tract involvement
is still uncommon (1–5% of all cases of endometriosis) and mainly concerns
the bladder and ureter according to a 8:1 ratio.7,8 There is only anecdotal
evidence of kidney or urethral endometriosis. The involvement of the urinary
tract shares many features with gynaecological presentations but, at the
same time, it has its own peculiar clinical and therapeutic characteristics and
requires dedicated urological management. 
Bladder and ureteral endometriosis are distinct clinical entities in terms of
aetiopathogenesis, symptomatology and possible consequences for renal
functionality. This affects the choice of diagnostic and therapeutic approach,
which in both conditions should aim to relieve the symptoms and preserve
renal function within acceptable morbidity levels. Treatment is still
controversial and based on expert opinions because the rarity of this
condition makes randomised studies almost unfeasible.
Bladder involvement should be regarded as a typical feature of deeply
infiltrating endometriosis, a particular form of endometriosis that penetrates
>5mm under the peritoneal surface,9 since only the cases in which the
detrusor is colonised are clinically significant. In contrast, superficial
endometriosis of the supravesical peritoneum is usually only an
intraoperative finding with no clinical impact. The presenting symptoms of
bladder endometriosis are lower urinary tract symptoms (LUTS: frequency,
tenesmus, painful micturition) and haematuria, but these characteristics can
vary considerably depending on the size and location of the lesion. They 
are often confused with symptoms of urinary tract infections, which are
extremely frequent in young women, as a mean delay to correct diagnosis
of up to four to five years confirms.10 Diagnostic doubts should arise 
based on the common evidence that symptoms are exacerbated in the 
pre-menstrual period and in cases of positive medical history for
endometriosis or pelvic surgery. In such cases, cystoscopy is highly advisable,
especially during the menstrual period, because evidence of a bluish
submucosal polycyclic lesion located in the trigone, posterior wall or dome
is pathognomonic. A biopsy is required only for doubtful cases. Before
explorative laparoscopy, pelvic transvaginal ultrasonography, computed
tomography (CT) or nuclear magnetic resonance (NMR) is advisable because
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these imaging techniques can contribute to halting the local spread of the
disease and ascertaining the potential involvement of the vesico-uterine
septum, which has specific surgical implications.11
Hormonal treatment is supported by some authors12 because it leads to
prompt relief of the symptoms, but relapses are common at therapy
discontinuation. Moreover, it does not permit pregnancy and the side
effects of long-term treatment are heavy. Therefore, the removal of the
lesion is generally regarded as necessary to cure the disease. Since
transurethral operative endoscopy cannot be radical due to the
extramucosal nature of endometriosis,12–14 the preferred option is surgical
resection by partial cystectomy. This fully removes the disease, allowing
durable recovery from the symptoms with acceptable morbidity, especially
when carried out laparoscopically.8,11 The technical complexity of the
procedure is low for dome locations, which are often isolated and easily
identifiable via transperitoneal access. Conversely, as recently reported in a
large surgical series,11 the base location can penetrate the vesico-uterine
septum and the procedure thus has to be radical, involving partial resection
of the anterior uterine wall. Moreover, such locations are frequently
associated with severe, diffuse pelvic endometriosis; in these cases
laparotomy access can be preferable because a number of additional
(gynaecological or intestinal) procedures could be necessary.11,14
Nevertheless, over the last few years the potential of laparoscopy has
certainly increased and its indications are becoming wider, as the data
published by referral institutions show.15
Ureteral locations are thought to develop from severe ovarian
endometriosis16 and are much more frequently associated with other pelvic
foci than with bladder locations.14 The pelvic ureteral tract is constantly
affected, even though a single case of upper ureteral involvement is
reported in the literature;17 therefore, endometriosis should be included in
the differential diagnosis of ureteral strictures in young women. The left
side is most frequently affected, which may be ascribed to the sigma
creating favourable local conditions for cell seeding retrogradely from the
uterine cavity.18 However, bilateral involvement is not infrequent and is
reported in 5–23% of cases.19 Ureteral endometriosis can take either an
extrinsic form (70–80% of cases), affecting the external ureteral tunics
through adherence to the surrounding structures or organs, or an intrinsic
form (20–30% of cases), when the endometriosic tissue subverts the
muscular layer or the ureteral mucosa, sometimes with an intraluminal
projection. The response of the ectopic endometrial tissue to hormone
stimulation results in cyclical bleeding of the lesion and its subsequent
desquamation, necrosis and fibrosis, all of which contribute significantly to
the development of ureteral stenosis. 
Intrinsic endometriosis may be associated with lateralised pathognomonic
macrohaematuria synchronised with the menstrual cycle, but such a
presentation is rarely found in daily clinical practice. Indeed, the presentation
is often silent (in up to 30% of cases), especially when the prejudice to the
upper urinary tract is higher and renal insufficiency or hydronephrotic
atrophy is diagnosed. Otherwise, symptoms are aspecifically related to the
obstruction of the ureter (renal colic or pyelonephritis; 70% of cases19) with
no radiological pathognomonic signs, and only in a minority of cases to the
menstrual cycle. However, a positive medical history for endometriosis
(around 60% of cases19) can really help to improve the diagnosis. The
difficulties associated with diagnosing ureteral endometriosis are indirectly
confirmed by the rate of kidney loss, which is high in historical series
(23–47%) and lower but still significant in contemporary ones (10%).19–21
Therefore, upper urinary tract evaluation by ultrasonography, CT, NMR or
urography is always highly advisable during the diagnosis and follow-up of
patients suffering from mild to severe pelvic endometriosis.
Medical treatment has been recommended by some authors,21 sometimes
in combination with ureteral stenting, but it is generally considered
ineffective since fibrosis, which follows the response of endometriosis to
hormone stimulation, contributes significantly to the development of
stenosis and consequential loss of responsiveness to hormone stimulation:
medical hormone suppression should therefore be regarded as an adjuvant
therapy to surgery or as a preventative therapy for relapses when total
hysterectomy with bilateral adnexectomy is not performed. Indeed, the need
for new surgery following a relapse falls from 27% of cases treated solely by
medical therapy to 3% of cases treated by hysterectomy with bilateral
adnexectomy.22 The young age of the patients, who often wish to have
children, means that this option is not always easy to accept.
The degree of recovery of renal function through urinary drainage
(nephrostomy or ureteral stenting), if necessary, can help to indicate
reconstructive surgery versus nephrectomy. Elective laparoscopic
ureterolysis should be chosen only for minimal, extrinsic and non-
obstructive ureteral involvement because it is not sufficiently radical in
cases of wider involvement of the ureter or intrinsic endometriosis,
which is hard to determine without histological examination.23,24
Conversely, when the urinary flow is obstructed and a dilation of the
upper urinary tract is evident, surgical resection represents a more
suitable option because it removes both the disease and the surrounding
fibrosis. Urinary tract continuity can be restored by ureteral termino-
terminal anastomosis only when the distal ureteral tract shows no signs
of endometriosis. In our opinion, the safest way to restore urinary
continuity is by ureteroneocystostomy, which does not use the ureteral
tract distal to the site of endometriosis – which is marked by a higher risk
of recurrence – and warrants tension- and disease-free anastomosis.
Moreover, this is the preferred procedure in cases of relapse of ureteral
endometriosis.19 Due to the complexity of the operation and the
frequent necessity of performing additional gynaecological or intestinal
procedures, laparotomic access may be the best though not the easiest
option, even though the feasibility of laparoscopy is known.25 ■
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